{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:37:53Z","timestamp":1788554273172,"version":"build-2803163510"},"reference-count":65,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK57993"],"award-info":[{"award-number":["DK57993"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK084567"],"award-info":[{"award-number":["P30DK084567"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008538","name":"PSC Partners Seeking a Cure","doi-asserted-by":"publisher","award":["93038002"],"award-info":[{"award-number":["93038002"]}],"id":[{"id":"10.13039\/100008538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","award":["FP00076782"],"award-info":[{"award-number":["FP00076782"]}],"id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Primary sclerosing cholangitis (PSC) is a pathogenically complex, chronic, fibroinflammatory disorder of the bile ducts without known etiology or effective pharmacotherapy. Emerging in vitro and in vivo evidence support fundamental pathophysiologic mechanisms in PSC centered on enterohepatic circulation. To date, no studies have specifically interrogated the chemical footprint of enterohepatic circulation in PSC. Herein, we evaluated the metabolome and lipidome of portal venous blood and bile obtained at the time of liver transplantation in patients with PSC (n = 7) as compared to individuals with noncholestatic, end-stage liver disease (viral, metabolic, etc. (disease control, DC, n = 19)) and to nondisease controls (NC, living donors, n = 12). Global metabolomic and lipidomic profiling was performed on serum derived from portal venous blood (portal serum) and bile using ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS\/MS) and differential mobility spectroscopy-mass spectroscopy (DMS-MS; complex lipid platform). The Mann\u2013Whitney U test was used to identify metabolites that significantly differed between groups. Principal-component analysis (PCA) showed significant separation of both PSC and DC from NC for both portal serum and bile. Metabolite set enrichment analysis of portal serum and bile demonstrated that the liver-disease cohorts (PSC and DC) exhibited similar enrichment in several metabolite categories compared to NC. Interestingly, the bile in PSC was uniquely enriched for dipeptide and polyamine metabolites. Finally, analysis of patient-matched portal serum and biliary metabolome revealed that these biological fluids were more homogeneous in PSC than in DC or NC, suggesting aberrant bile formation and enterohepatic circulation. In summary, PSC and DC patients exhibited alterations in several metabolites in portal serum and bile, while PSC patients exhibited a unique bile metabolome. These specific alterations in PSC are amenable to hypothesis testing and, potentially, therapeutic pharmacologic manipulation.<\/jats:p>","DOI":"10.3390\/ijms19103188","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T11:07:51Z","timestamp":1539688071000},"page":"3188","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis"],"prefix":"10.3390","volume":"19","author":[{"given":"Pamela S.","family":"Tietz-Bogert","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA"},{"name":"Center for Cell Signaling in Gastroenterology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9958-0380","authenticated-orcid":false,"given":"Minsuk","family":"Kim","sequence":"additional","affiliation":[{"name":"Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA"},{"name":"Division of Surgical Research, Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Cheung","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9104-1702","authenticated-orcid":false,"given":"James H.","family":"Tabibian","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA"},{"name":"Division of Gastroenterology, Department of Medicine, Olive View-UCLA Medical Center, Sylmar, CA 91342, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Heimbach","sequence":"additional","affiliation":[{"name":"Division of Transplant Surgery, Mayo Clinic College of Medicine, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Rosen","sequence":"additional","affiliation":[{"name":"Division of Transplant Surgery, Mayo Clinic College of Medicine, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumitha","family":"Nandakumar","sequence":"additional","affiliation":[{"name":"Seres Therapeutics, Cambridge, MA 02139, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos N.","family":"Lazaridis","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA"},{"name":"Center for Cell Signaling in Gastroenterology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas F.","family":"LaRusso","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA"},{"name":"Center for Cell Signaling in Gastroenterology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyun","family":"Sung","sequence":"additional","affiliation":[{"name":"Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA"},{"name":"Division of Surgical Research, Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"O\u2019Hara","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA"},{"name":"Center for Cell Signaling in Gastroenterology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis\u2014A comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary Sclerosing Cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2006-933565","article-title":"Liver transplantation in primary sclerosing cholangitis","volume":"26","author":"Bjoro","year":"2006","journal-title":"Semin. Liver Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/gutjnl-2016-312137","article-title":"Primary sclerosing cholangitis: 50 years of a gut-liver relationship and still no love?","volume":"65","author":"Karlsen","year":"2016","journal-title":"Gut"},{"key":"ref_5","first-page":"1","article-title":"Hepatic blood flow: Morphologic aspects and physiologic regulation","volume":"21","author":"Rappaport","year":"1980","journal-title":"Int. Rev. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1152\/physrev.00027.2008","article-title":"The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair","volume":"89","author":"Vollmar","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/ibd.22938","article-title":"Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease","volume":"18","author":"Boonstra","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Bajer","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/gutjnl-2016-311915","article-title":"The gut-adherent microbiota of PSC-IBD is distinct to that of IBD","volume":"66","author":"Quraishi","year":"2017","journal-title":"Gut"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gutjnl-2016-312180","article-title":"Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis","volume":"66","author":"Ruhlemann","year":"2017","journal-title":"Gut"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/apt.14540","article-title":"Review article: The evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis","volume":"47","author":"Damman","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.12232","article-title":"Randomised clinical trial: Vancomycin or metronidazole in patients with primary sclerosing cholangitis\u2014A pilot study","volume":"37","author":"Tabibian","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1074\/jbc.M109.041640","article-title":"NFkappaB p50-CCAAT\/enhancer-binding protein beta (C\/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection","volume":"285","author":"Splinter","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"30352","DOI":"10.1074\/jbc.M111.269464","article-title":"Cholangiocyte N-Ras protein mediates lipopolysaccharide-induced interleukin 6 secretion and proliferation","volume":"286","author":"Splinter","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Trussoni, C.E., Tabibian, J.H., Splinter, P.L., and O\u2019Hara, S.P. (2015). Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR). PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125793"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.27927","article-title":"Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis","volume":"63","author":"Tabibian","year":"2016","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/liv.12680","article-title":"Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis","volume":"35","author":"Bell","year":"2015","journal-title":"Liver Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dld.2011.10.025","article-title":"Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study","volume":"44","author":"Trottier","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S0016-5085(98)70033-2","article-title":"Quantification of gluconeogenesis in cirrhosis: Response to glucagon","volume":"115","author":"Bugianesi","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_23","first-page":"E529","article-title":"Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis","volume":"276","author":"Petersen","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.22063","article-title":"Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease","volume":"47","author":"Charlton","year":"2008","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1183\/09031936.00027412","article-title":"Dehydroepiandrosterone has strong antifibrotic effects and is decreased in idiopathic pulmonary fibrosis","volume":"42","author":"Rangel","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.3748\/wjg.v22.i27.6201","article-title":"Pleiotropic effects of statins in the diseases of the liver","volume":"22","author":"Janicko","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/ajg.2017.170","article-title":"Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis","volume":"112","author":"Kamal","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/hep.22402","article-title":"Statins in liver disease: A molehill, an iceberg, or neither?","volume":"48","author":"Argo","year":"2008","journal-title":"Hepatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"39573","DOI":"10.1038\/srep39573","article-title":"Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis","volume":"6","author":"Milkiewicz","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fmed.2017.00163","article-title":"Interactions between Bacteria and Bile Salts in the Gastrointestinal and Hepatobiliary Tracts","volume":"4","author":"Urdaneta","year":"2017","journal-title":"Front. Med. (Lausanne)"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.26225","article-title":"Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis","volume":"57","author":"Bechmann","year":"2013","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12072-016-9769-7","article-title":"Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge","volume":"11","author":"Zweers","year":"2017","journal-title":"Hepatol. Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tips.2007.03.002","article-title":"FXR: A promising target for the metabolic syndrome?","volume":"28","author":"Cariou","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cphy.c120023","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2004.10.012","article-title":"The impact of intestinal microflora on serum bilirubin levels","volume":"42","author":"Vitek","year":"2005","journal-title":"J. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbagen.2007.08.010","article-title":"The Yin and Yang of lactosylceramide metabolism: implications in cell function","volume":"1780","author":"Chatterjee","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/gast.2003.50100","article-title":"Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes","volume":"124","author":"Spirli","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1053\/gast.2003.50122","article-title":"When bile ducts say NO: The good, the bad, and the ugly","volume":"124","author":"Trauner","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1471-4159.2007.04822.x","article-title":"Lactosylceramide: A lipid second messenger in neuroinflammatory disease","volume":"103","author":"Won","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3727\/105221616X692568","article-title":"Regulators of Cholangiocyte Proliferation","volume":"17","author":"Hall","year":"2017","journal-title":"Gene Expr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.cellsig.2014.01.003","article-title":"Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K\/Akt signaling","volume":"26","author":"Xiao","year":"2014","journal-title":"Cell Signal."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1182\/blood.V100.4.1454.h81602001454_1454_1464","article-title":"Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils","volume":"100","author":"Iwabuchi","year":"2002","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","article-title":"Secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Walkley","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cphy.c120027","article-title":"Bile formation and secretion","volume":"3","author":"Boyer","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.3748\/wjg.14.5641","article-title":"Physiology of bile secretion","volume":"14","author":"Esteller","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/hep.510280524","article-title":"The modified dipeptide, enalapril, an angiotensin-converting enzyme inhibitor, is transported by the rat liver organic anion transport protein","volume":"28","author":"Pang","year":"1998","journal-title":"Hepatology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/hep.510300529","article-title":"Hepatobiliary transport of bile acid amino acid, bile acid peptide, and bile acid oligonucleotide conjugates in rats","volume":"30","author":"Petzinger","year":"1999","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/B978-0-12-800223-0.00005-0","article-title":"Organic anion-transporting polypeptides","volume":"73","author":"Stieger","year":"2014","journal-title":"Curr. Top. Membr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jbiosc.2011.03.002","article-title":"Screening of peptides with a high affinity to bile acids using peptide arrays and a computational analysis","volume":"112","author":"Takeshita","year":"2011","journal-title":"J. Biosci. Bioeng."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/BJ20090598","article-title":"Polyamine catabolism and disease","volume":"421","author":"Casero","year":"2009","journal-title":"Biochem. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"14904","DOI":"10.1074\/jbc.R116.731661","article-title":"Functions of Polyamines in Mammals","volume":"291","author":"Pegg","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"26428","DOI":"10.1074\/jbc.M804714200","article-title":"Identification and characterization of a diamine exporter in colon epithelial cells","volume":"283","author":"Uemura","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"G899","DOI":"10.1152\/ajpgi.90507.2008","article-title":"Spermidine\/spermine-N1-acetyltransferase ablation protects against liver and kidney ischemia-reperfusion injury in mice","volume":"296","author":"Zahedi","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2012.04.041","article-title":"S-Adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility","volume":"57","author":"Anstee","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1074\/mcp.M115.055772","article-title":"Methylthioadenosine (MTA) Regulates Liver Cells Proteome and Methylproteome: Implications in Liver Biology and Disease","volume":"15","author":"Bigaud","year":"2016","journal-title":"Mol. Cell. Proteom."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2958.2008.06126.x","article-title":"A multifaceted role for polyamines in bacterial pathogens","volume":"68","author":"Shah","year":"2008","journal-title":"Mol. Microbiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"E10455","DOI":"10.1073\/pnas.1711625114","article-title":"Microbial pathway for anaerobic 5\u2032-methylthioadenosine metabolism coupled to ethylene formation","volume":"114","author":"North","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1099\/00221287-71-2-267","article-title":"The characterization of dipeptidases from Escherichia coli","volume":"71","author":"Payne","year":"1972","journal-title":"J. Gen. Microbiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/AEM.02044-14","article-title":"Incorporation of exogenous fatty acids protects Enterococcus faecalis from membrane-damaging agents","volume":"80","author":"Saito","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biochi.2017.06.015","article-title":"Exogenous fatty acid metabolism in bacteria","volume":"141","author":"Yao","year":"2017","journal-title":"Biochimie"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.3748\/wjg.v12.i22.3553","article-title":"Bile acid interactions with cholangiocytes","volume":"12","author":"Xia","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"ref_62","first-page":"175","article-title":"Regulation of hepatobiliary transporters during liver injury","volume":"Volume 9","author":"McQueen","year":"2010","journal-title":"Comprehensive Toxicology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/liv.13092","article-title":"Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis","volume":"36","author":"Zweers","year":"2016","journal-title":"Liver Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.11.019","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"48","author":"Said","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"W71","DOI":"10.1093\/nar\/gkq329","article-title":"MSEA: A web-based tool to identify biologically meaningful patterns in quantitative metabolomic data","volume":"38","author":"Xia","year":"2010","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/10\/3188\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:25:54Z","timestamp":1760196354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/10\/3188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":65,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["ijms19103188"],"URL":"https:\/\/doi.org\/10.3390\/ijms19103188","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]}}}